{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:56:18Z","timestamp":1783695378384,"version":"3.55.0"},"reference-count":23,"publisher":"American Diabetes Association","issue":"2","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.2337\/diacare.29.02.06.dc05-2048","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T22:41:57Z","timestamp":1147300917000},"page":"469-471","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":28,"title":["Insulin Signaling, Glucose Metabolism, and the Angiotensin II Signaling System"],"prefix":"10.2337","volume":"29","author":[{"given":"Paul A.","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Nutrition, University of California, Davis, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pagnin","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Semplicini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Avogaro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo A.","family":"Calo\u0300","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031218015256300_R1","doi-asserted-by":"crossref","unstructured":"Taniyama Y, Hitomi H, Shah A, Alexander RW, Griendling KK: Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol\u200825:1142\u20131147, 2005","DOI":"10.1161\/01.ATV.0000164313.17167.df"},{"key":"2022031218015256300_R2","doi-asserted-by":"crossref","unstructured":"Calo\u0300 LA, Pessina AC, Semplicini A: Angiotensin II signaling in the Bartter\u2019s and Gitelman\u2019s syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev\u200812:17\u201326, 2005","DOI":"10.2165\/00151642-200512010-00004"},{"key":"2022031218015256300_R3","doi-asserted-by":"crossref","unstructured":"Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D: Bartter\u2019s and Gitelman\u2019s syndromes: from gene to clinic (Review). Nephron Physiol\u200896:65\u201378, 2004","DOI":"10.1159\/000076752"},{"key":"2022031218015256300_R4","unstructured":"Calo\u0300 LA: A mirror instead of a looking glass to understand vascular tone control in humans: the utility of studies in Bartter\u2019s\/Gitelmen\u2019s syndromes. Kidney Int. In press"},{"key":"2022031218015256300_R5","doi-asserted-by":"crossref","unstructured":"Calo\u0300 LA, Pagnin E, Davis PA, Sartori M, Ceolotto G, Pessina AC, Semplicini A: Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter\u2019s\/Gitelman\u2019s sydrome: a role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab\u200889:4153\u20134157, 2004","DOI":"10.1210\/jc.2004-0498"},{"key":"2022031218015256300_R6","doi-asserted-by":"crossref","unstructured":"Calo\u0300 L, Ceolotto G, Milani M, Pagnin E, van den Heuvel LP, Sartori M, Davis PA, Costa R, Semplicini A: Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int\u200860:882\u2013889, 2001","DOI":"10.1046\/j.1523-1755.2001.060003882.x"},{"key":"2022031218015256300_R7","doi-asserted-by":"crossref","unstructured":"Calo\u0300 L, Davis PA, Semplicini A: Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity. Kidney Int\u200861:353\u2013354, 2002","DOI":"10.1046\/j.1523-1755.2002.00128.x"},{"key":"2022031218015256300_R8","doi-asserted-by":"crossref","unstructured":"Di Virgilio F, Calo\u0300 L, Cantaro S, Favaro S, Piccoli A, Borsatti A: Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter\u2019s syndrome. Clin Sci\u200872:483\u2013488, 1987","DOI":"10.1042\/cs0720483"},{"key":"2022031218015256300_R9","doi-asserted-by":"crossref","unstructured":"Calo\u0300 L, D\u2019Angelo A, Cantaro S, Rizzolo M, Favaro S, Antonello A, Borsatti A: Intracellular calcium signalling and vascular reactivity in Bartter\u2019s syndrome. Nephron\u200872:570\u2013573, 1996","DOI":"10.1159\/000188941"},{"key":"2022031218015256300_R10","unstructured":"Calo\u0300 L, Davis PA, Milani M, Cantaro S, Antonello A, Favaro S, D\u2019Angelo A: Increased endothelial nitric oxide synthase mRNA level in Bartter\u2019s and Gitelman\u2019s syndrome: relationship to vascular reactivity. Clin Nephrol\u200851:12\u201317, 1999"},{"key":"2022031218015256300_R11","doi-asserted-by":"crossref","unstructured":"Calo\u0300 L, D\u2019Angelo A, Cantaro S, Bordin MC, Favaro S, Antonello A, Borsatti A: Increased urinary NO2\u2013\/NO3\u2013 and cyclic GMP levels in patients with Bartter\u2019s syndrome: relationship to vascular reactivity. Am J Kidney Dis\u200827:874\u2013879, 1996","DOI":"10.1016\/S0272-6386(96)90514-4"},{"key":"2022031218015256300_R12","doi-asserted-by":"crossref","unstructured":"Calo\u0300 L, Cantaro S, Calabro A, Piarulli F, Rizzolo M, Favaro S, Antonello A, Crepaldi G, Borsatti A: Endothelium-derived vasoactive substances in Bartter\u2019s syndrome. Angiology\u200846:905\u2013913, 1995","DOI":"10.1177\/000331979504601005"},{"key":"2022031218015256300_R13","doi-asserted-by":"crossref","unstructured":"Calo\u0300 LA, Pagnin E, Davis PA, Sartori M, Semplicini A: Oxidative stress related factors in Bartter\u2019s and Gitelman\u2019s syndromes: relevance for angiotensin II signalling. Nephrol Dial Transplant\u200818:1518\u20131525, 2003","DOI":"10.1093\/ndt\/gfg204"},{"key":"2022031218015256300_R14","doi-asserted-by":"crossref","unstructured":"Calo\u0300 L, Sartore G, Bassi A, Basso C, Bertocco S, Marin R, Zambon S, Cantaro S, D\u2019Angelo A, Davis PA, Manzato E, Crepaldi G: Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter\u2019s and Gitelman\u2019s syndrome). J Hypertens\u200816:1001\u20131008, 1998","DOI":"10.1097\/00004872-199816070-00014"},{"key":"2022031218015256300_R15","doi-asserted-by":"crossref","unstructured":"Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao PK: Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3 kinase\/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol\u200824:1842\u20131847, 2004","DOI":"10.1161\/01.ATV.0000142813.33538.82"},{"key":"2022031218015256300_R16","doi-asserted-by":"crossref","unstructured":"Sowers JR: Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol\u2008286:H1597\u2013H1602, 2004","DOI":"10.1152\/ajpheart.00026.2004"},{"key":"2022031218015256300_R17","doi-asserted-by":"crossref","unstructured":"Pagnin E, Davis PA, Sartori M, Semplicini A, Pessina AC, Calo\u0300 LA: Rho kinase and PAI-1 in Bartter\u2019s\/Gitelman\u2019s syndromes: relationship to angiotensin II signaling. J Hypertens\u200822:1963\u20131969, 2004","DOI":"10.1097\/00004872-200410000-00019"},{"key":"2022031218015256300_R18","doi-asserted-by":"crossref","unstructured":"Pagnin E, Semplicini A, Sartori M, Pessina AC, and Calo\u0300 LA: Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter\u2019s and Gitelman\u2019s syndromes: relevance for the pathophysiology of hypertension. Am J Hypertens\u200818:1200\u20131205, 2005","DOI":"10.1016\/j.amjhyper.2005.03.747"},{"key":"2022031218015256300_R19","doi-asserted-by":"crossref","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care\u200824:539\u2013548, 2001","DOI":"10.2337\/diacare.24.3.539"},{"key":"2022031218015256300_R20","doi-asserted-by":"crossref","unstructured":"Mita S, Kobayashi N, Yoshida K, Nakano S, Matsuoka H: Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. J Hypertens\u200823:87\u201396, 2005","DOI":"10.1097\/00004872-200501000-00017"},{"key":"2022031218015256300_R21","doi-asserted-by":"crossref","unstructured":"Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A: Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase\/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem\u2008279:8919\u20138929, 2004","DOI":"10.1074\/jbc.M309660200"},{"key":"2022031218015256300_R22","doi-asserted-by":"crossref","unstructured":"Avogaro A, Pagnin E, Calo L: Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab\u200888:1753\u20131759, 2003","DOI":"10.1210\/jc.2002-021025"},{"key":"2022031218015256300_R23","doi-asserted-by":"crossref","unstructured":"Pagnin E, Fadini G, de Toni R, Tiengo A, Calo L, Avogaro A: Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab\u200890:1130\u20131136, 2005","DOI":"10.1210\/jc.2004-1283"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/2\/469\/594788\/zdc002060469-a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/2\/469\/594788\/zdc002060469-a.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T18:57:33Z","timestamp":1647111453000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/29\/2\/469\/26317\/Insulin-Signaling-Glucose-Metabolism-and-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.29.02.06.dc05-2048","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}